Y
HN Search
Hacker News Search
new
|
comments
|
top
|
jobs
alexosh1
searching Neon…
1.
▲
2.
▲
3.
▲
4.
▲
5.
▲
6.
▲
4 ms
·
1.
▲
by
alexosh1
6y ago
Oops, yeah sorry. Graphql API in front of MySQL
2.
▲
by
alexosh1
6y ago
Thanks Benjismith!
3.
▲
by
alexosh1
6y ago
The US is kind of unique in a lot of its healthcare dysfunctions and there are a lot of individual policies that might help. For example, one thing most other developed countries do is have a central state agency negotiate prices for drugs
4.
▲
by
alexosh1
6y ago
Well, there's some technical measures we've taken and some practical ones to ensure we work to be profitable but remain focused primarily on improving public health and helping patients. On the technical level, we incorporated as
5.
▲
by
alexosh1
6y ago
Short answer... it's complicated. And it's intentionally complicated to make it difficult for people to understand how they are getting ripped off on the price of drugs and by who. Here's a brief video that breaks down some o
6.
▲
by
alexosh1
6y ago
It will be a sterile fill-finish facility. The facility will fill vials of sterile injectable medicine. Those tend to be the drugs which are most affected by shortages and price gouging overall. The facility will just do finished drug produ
7.
▲
by
alexosh1
6y ago
Ideally yeah, would be good if we didn't need to exist. There are a variety of policy initiatives the US could likely implement to bring costs down. My kind of mindset with the company though is I am a nobody from nowhere, and congress
8.
▲
by
alexosh1
6y ago
O should also point out, these roles can be remote
9.
▲
by
alexosh1
6y ago
Currently our frontend is react, backend node.js, and a MySQL database with a graphql API (edit). Would be looking for folks to help make a more robust consumer facing site as we add products and different types of customers. We've be
10.
▲
by
alexosh1
6y ago
Hi guys, Alex Oshmyansky here, CEO of the Mark Cuban Cost Plus Drug Company. Crazy to see our little project at the top of Hacker News! We're planning to introduce a lot more drugs with transparent prices later this year, cutting out m